The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study.
 
Michael Offin
Honoraria - OncLive
Consulting or Advisory Role - American Society for Radiation Oncology; Jazz Pharmaceuticals; Novartis; Pfizer; Pfizer; Pfizer; PharmaMar; Targeted Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation
 
Yonit Lavin
No Relationships to Disclose
 
Matthew Zatzman
No Relationships to Disclose
 
Jennifer L. Sauter
Stock and Other Ownership Interests - Chemed; Merck; Pfizer; Thermo Fisher Scientific
Consulting or Advisory Role - Vivace Therapeutics
 
Nicholas Ceglia
No Relationships to Disclose
 
William D. Travis
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
 
Rania G. Aly
No Relationships to Disclose
 
Andreas Rimner
Honoraria - More Health
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Pfizer (Inst); Varian Medical Systems (Inst)
 
Annemarie Shepherd
Stock and Other Ownership Interests - Arcellx; Doximity
 
Charles B. Simone
Honoraria - Varian Medical Systems
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; BerGenBio; Daiichi Sankyo/Astra Zeneca; Merus; Mirati Therapeutics; Pfizer; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Genentech
 
Michelle S. Ginsberg
No Relationships to Disclose
 
Andrew Chow
Employment - Merck
Stock and Other Ownership Interests - 10x Genomics; Illumina; Moderna Therapeutics; Pacific Biosciences; PDS Biotechnology
 
Alvaro Quintanal-Villalonga
Honoraria - AstraZeneca
Research Funding - Duality Biologics; Foghorn Therapeutics; Jazz Pharmaceuticals
 
Sohrab P Shah
No Relationships to Disclose
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Auron Therapeutics; Bridge Medicines; D2G Oncology; Daiichi Sankyo/UCB Japan; DISCO; Earli; Genentech/Roche; Harpoon Therapeutics; Jazz Pharmaceuticals; Kowa; Merck
Research Funding - Daiichi Sankyo (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Valerie W. Rusch
Other Relationship - NIH/Coordinating Center for Clinical Trials
(OPTIONAL) Uncompensated Relationships - Cancer Research UK
 
Prasad S. Adusumilli
Consulting or Advisory Role - Atara Biotherapeutics; Bayer; BioArdis; Carisma Therapeutics; ImmPACT-Bio; Imugene; Orion; Outpace Bio
Research Funding - Atara Biotherapeutics
Patents, Royalties, Other Intellectual Property - Atara Biotherapeutics
 
Marjorie Glass Zauderer
Honoraria - Medscape
Consulting or Advisory Role - Curis
Research Funding - Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Millennium (Inst); Polaris (Inst); Sellas Life Sciences (Inst); Vivace Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation